oncology

You have access
Signaling Pathways That Drive ¹⁸F-FDG Accumulation in Cancer
Jessica R. Salas and Peter M. Clark

Journal of Nuclear Medicine May 1, 2022, 63 (5) 659-663; DOI: https://doi.org/10.2967/jnumed.121.262609
You have access
PET/MRI Improves Management of Children with Cancer
Lucia Baratto, K. Elizabeth Hawk, Lisa States, Jing Qi, Sergios Gatidis, Louise Kiru and Heike E. Daldrup-Link

Journal of Nuclear Medicine October 1, 2021, 62 (10) 1334-1340; DOI: https://doi.org/10.2967/jnumed.120.259747
You have access
Update on the Evaluation of Thyroid Nodules
Victor J. Bernet and Ana-Maria Chindris

Journal of Nuclear Medicine July 1, 2021, 62 (Supplement 2) 13S-19S; DOI: https://doi.org/10.2967/jnumed.120.246025
You have access
Current and Emerging Clinical Applications of PSMA PET Diagnostic Imaging for Prostate Cancer
Andrea Farolfi, Letizia Calderoni, Francesco Mattana, Riccardo Mei, Sivi Telo, Stefano Fanti and Paolo Castellucci

Journal of Nuclear Medicine May 10, 2021, 62 (5) 596-604; DOI: https://doi.org/10.2967/jnumed.120.257238
You have access
FAPI PET/CT: Will It End the Hegemony of ¹⁸F-FDG in Oncology?
Rodney J. Hicks, Peter J. Roselt, Kumarswamy G. Kallur, Richard W. Tothill and Linda Mileshkin

Journal of Nuclear Medicine March 1, 2021, 62 (3) 296-302; DOI: https://doi.org/10.2967/jnumed.120.256271
Open Access
Immuno-PET Detects Changes in Multi-RTK Tumor Cell Expression Levels in Response to Targeted Kinase Inhibition
Patricia M.R. Pereira, Jalen Norfleet, Jason S. Lewis and Freddy E. Escorcia

Journal of Nuclear Medicine March 1, 2021, 62 (3) 366-371; DOI: https://doi.org/10.2967/jnumed.120.244897
You have access
Synthesis of the PET Tracer ¹²⁴I-Trametinib for MAPK/ERK Kinase Distribution and Resistance Monitoring
Edwin C. Pratt, Elizabeth Isaac, Evan P. Stater, Guangbin Yang, Ouathek Ouerfelli, Nagavarakishore Pillarsetty and Jan Grimm

Journal of Nuclear Medicine December 1, 2020, 61 (12) 1845-1850; DOI: https://doi.org/10.2967/jnumed.120.241901
You have access
The Biodistribution of a CD3 and EpCAM Bispecific T-Cell Engager Is Driven by the CD3 Arm
Frans V. Suurs, Grit Lorenczewski, Sabine Stienen, Matthias Friedrich, Elisabeth G.E. de Vries, Derk Jan A. de Groot and Marjolijn N. Lub-de Hooge

Journal of Nuclear Medicine November 1, 2020, 61 (11) 1594-1601; DOI: https://doi.org/10.2967/jnumed.120.241877
You have access
Immune Checkpoint Imaging in Oncology: A Game Changer Toward Personalized Immunotherapy?
Susanne Lütje, Georg Feldmann, Markus Essler, Peter Brossart and Ralph A. Bundschuh

Journal of Nuclear Medicine August 1, 2020, 61 (8) 1137-1144; DOI: https://doi.org/10.2967/jnumed.119.237891
You have access
¹⁸F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of Outcome
Anne-Ségolène Cottereau, Christophe Nioche, Anne-Sophie Dirand, Jérôme Clerc, Franck Morschhauser, Olivier Casasnovas, Michel Meignan and Irène Buvat

Journal of Nuclear Medicine January 1, 2020, 61 (1) 40-45; DOI: https://doi.org/10.2967/jnumed.119.229450

Main menu

User menu

Search

oncology

Pages